Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?

Similar documents
What do the guidelines say?

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

Coronary Artery Disease: Revascularization (Teacher s Guide)

The MAIN-COMPARE Study

MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines

Supplementary Material to Mayer et al. A comparative cohort study on personalised

LM stenting - Cypher

Controversies in Cardiac Surgery

CASE from South Korea

Clinical guideline Published: 23 July 2011 nice.org.uk/guidance/cg126

The SYNTAX-LE MANS Study

Benefit of Performing PCI Based on FFR

Surgery Grand Rounds

Unprotected Left Main Coronary Artery Disease in Patients With Low Predictive Risk of Mortality

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017

Solving the Dilemma of Ostial Stenting: A Case Series Illustrating the Flash Ostial System

Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011

Kurdistan Technique for the Treatment of Unprotected Trifurcation Left Main Stem Coronary Artery Lesion: Case Report

FAME STUDY: 2-year Follow-Up & CLINICAL SUBGROUP ANALYSIS

Stable Angina: Indication for revascularization and best medical therapy

FFR in Multivessel Disease

PROMUS Element Experience In AMC

Revascularization In HFrEF: Are We Close To The Truth. Ali Almasood

APPENDIX F: CASE REPORT FORM

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

Δημήτριος Αγγοσράς, FETCS

Unprotected LM intervention

Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents

CONTEMPORARY USE OF ARTERIAL GRAFTS DURING CORONARY ARTERY BYPASS SURGERY: PARADIGM SHIFT? OR A LITTLE (MORE) TALK THAT NEEDS A LOT MORE ACTION

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

ΑΝΤΙΓΝΩΜΙΕΣ ΣΤΗΝ ΕΠΕΜΒΑΤΙΚΗ ΚΑΡΔΙΟΛΟΓΙΑ:Νόσος στελέχους Αγγειοπλαστική

JMSCR Vol 07 Issue 01 Page January 2018

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018

Gender-Based Outcomes in Percutaneous Coronary Intervention with Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic

Michael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX

ARMYDA-RECAPTURE (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) trial

FastTest. You ve read the book now test yourself

Chapter 29 Left Main Intervention in the Light of EXCEL and NOBLE Trials

Acute Myocardial Infarction

Severe Coronary Vasospasm Complicated with Ventricular Tachycardia

Declaration of conflict of interest NONE

PCI for LMCA lesions A Review of latest guidelines and relevant evidence

Alex versus Xience Registry Preliminary report

Chronic Total Occlusion: a case for coronary artery bypass grafting

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital

Clinical case in perspective. Cases from Poland

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Timing of Surgery After Percutaneous Coronary Intervention

How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting

TCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI

Pathology of percutaneous interventions (PCI) in coronary arteries. Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France

Clinical Appropriateness Guidelines: Percutaneous Coronary Intervention

FRACTIONAL FLOW RESERVE: STANDARD OF CARE

Ischemic Heart Disease Interventional Treatment

Current Management of Coronary Artery Disease with Special Emphasis on the Elderly and Diabetic

Impact of Chronic Kidney Disease on Long-Term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary Intervention

Advances in Cardiovascular Diagnosis and Therapy. No disclosure or conflicts. Outline

Intervention: How and to which extent is technology helping us?

Important LM bifurcation studies update

Case Report Coronary Artery Perforation and Regrowth of a Side Branch Occluded by a Polytetrafluoroethylene-Covered Stent Implantation

Fractional Flow Reserve. A physiological approach to guide complex interventions

Count Down to COMBAT

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Ziyad Ghazzal MD, FACC, FSCAI Professor of Medicine Deputy Vice President/Dean Associate Dean for Clinical Affairs American University of Beirut

Management of Patients Undergoing Coronary Artery Revascularization

Summary HTA. Drug-eluting stents vs. coronary artery bypass-grafting. HTA-Report Summary. Gorenoi V, Dintsios CM, Schönermark MP, Hagen A

Patients in whom PCI is preferred over CABG _ Aleksander Ernst Clinical Hospital Center Zagreb University of Zagreb School of Medicine Zagreb, CROATIA

Diagnosis and Management of Acute Myocardial Infarction

Abstract Background: Methods: Results: Conclusions:

Lésions du tronc commun: Reste t il une place pour la chirugie? Pierre Deharo, CHU TIMONE, Marseille

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center

COMBAT- Revised Protocol

Robotic Hybrid Coronary Revascularization

The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study

There s Triple Vessel Disease and Triple Vessel Disease: Risk Assessment

The MAIN-COMPARE Registry

Rationale for Percutaneous Revascularization ESC 2011

Ischemic Heart Disease Interventional Treatment

R&M Solutions

SYNTAX III REVOLUTION Trial Press briefing conference. Prof. Patrick W. Serruys MD, PhD Principal Investigator Imperial College of London

Application of Appropriate Use Criteria in Clinical Care of CAD. Peter K. Smith, MD Professor and Chief Thoracic Surgery Duke University 4/29/2012

Ischaemic heart disease. IInd Chair and Clinic of Cardiology

Fractional Flow Reserve: Review of the latest data

Patient. Clinical data Indications: Operation date. Comorbidities: Patient code Birth date: / /

Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center

DESCRIPTION: Percentage of patients aged 18 years and older undergoing isolated CABG surgery who received an IMA graft

Stable Ischemic Heart Disease. Ivan Anderson, MD RIHVH Cardiology

Le# Main Interven-on: When Is It Appropriate. Femi Philip, MD Assistant Professor Of Medicine UC Davis

Management of Multivessel CAD: Stenting or CABG?

J. Schwitter, MD, FESC Section of Cardiology

Supplementary Online Content

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines)

Treatment of Left Main Coronary Trifurcation Lesions with the Paclitaxel Drug-Eluting Stent: Mid-Term Outcomes from a Tertiary Medical Center

Prolonged Oral Morphine Therapy for Severe Angina Pectoris

Transcription:

Cronicon OPEN ACCESS CARDIOLOGY Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)? Valentin Hristov* Department of Cardiology, Specialized cardiology hospital for active treatment, Pleven, Bulgaria *Corresponding Author: Valentin Hristov, Department of Cardiology, Specialized cardiology hospital for active treatment, Pleven, Bulgaria. Received: October 16, 2015; Published: October 24, 2015 Abstract According to the World Health Organization (WHO) list of the 10 most common causes of death is headed from ischemic heart disease (IHD). Stable angina pectoris (SAP) is one of the forms of IHD. It affecting the vessels of the heart - the left and right coronary artery. Of particular note are stenoses covering the left main of the left coronary artery, because it supplies the majority of the heart muscle. In the era of coronary angioplasty with stent implantation, bypass surgery is still the golden standard in the treatment of left main stenosis. In clinical practice, some of the patients with stable angina pectoris have a stenosis of the left main. Today, with the advent of the DES stents possible implementation of the PCI of the left main with reduced risk of restenosis. Of course coronary angioplasty did not completely replace surgical revascularization by coronary artery bypass. Which solution is the medical properly and best for the patient is taken by the Heart Team. We comply with the calculated Syntax Score. The study SYNTAX - PCI (TAXUS DES) vs CABG is the - largest randomized study on this issue. Keywords: Left main stenosis; Angioplasty; Drug eluting stent (DES); Percutaneous coronary intervention (PCI); Coronary artery bypass graft surgery (CABG) Left main stenoses are important because the left coronary artery blood supply about 75% of the myocardium. These stenoses require quick decision and urgently conduct. They meet at 4% - 10% of patients with coronary angiography. These patients are at high risk of death. What matters is the anatomy of the stenosis - ostial, middle or distal segment - (bifurcation, trifurcation) (Figure 1). On the other hand are important clinical condition of the patient, the left ventricular function, whether the patient is suitable for surgery or not, heavy calcification of left main, protected and unprotected left main [1]. Figure 1

In an attempt to solve the dilemma which method of revascularization is suitable for certain patients were conducted significant number of randomized trials. In a Meta analysis of 23 randomized studies comparing survival in patients after PCI and CABG after 10 years of follow that there is no difference in mortality between the two groups. In a Meta analysis of 16 observational studies of 1278 patients offer percutaneous angioplasty DES to be safe in following them, citing the fact for hospital mortality 2.3% and 5.5% mortality after the last track - about 10 months. Evaluated 1108 patients who undergo coronary angioplasty with stent implantation within six years and comparing them with 1138 patients experienced coronary artery bypass. They do not establish differences in mortality, stroke and myocardial infarction between the two groups. However, revealing a greater incidence of revascularization in the group of coronary angioplasty. Despite these data taking into account the fact that within 1 year occluded about 35% of vein grafts and 8% of arterial grafts - left internal mammary artery can be considered that the DES stents for revascularization of stem stenosis. Syntax study - Synergy between PCI with Taxus DES and Cardiac Surgery is the largest randomized controlled trial PCI with DES (TAXUS) versus CABG conducted in 87 centers in Europe and the US. Record the activity of the heart Team consisting of invasive cardiologist and cardiac surgeon [2]. They must reach consensus on the future revascularization. This problem is present in Guidelines of the European Society of Cardiology for the treatment of stable angina pectoris in 2013-2013 ESC Guidelines for the management of stable coronary disease. After optimal medical therapy and the lack of effect is paying attention to invasive treatment of patients with multivessel disease and those with left main stenosis [3]. 112 Figure 2 Case report In our clinic was admitted a patient with complaining of chest pain with typical astringent character and irradiation to hands, back and throat. Complaints are accompanied by shortness of breath and sweating. The pain occurs in the morning after getting up and physical exercise. Disappear for 2-3 min. at rest. Chest pain last three days before admission in the clinic and lasted 15 minutes.

113 Figure 3 The patient had pre existing coronary angioplasty with implantation of two DES stents in LAD 1 year ago. Risk factors - hypertension and dyslipidemia. Conduct regular therapy with aspirin 100 mg., Clopidogrel 75 mg., Beta blockers, Calcium channel blockers, Angiotensin receptor blockers, Nitrate. No increase in markers of myocardial damage - troponin, MB fraction of creatine kinase and creatine kinase. From coronary angiography was establishing persistent optimal stent result of LAD and 80% stenosis in the middle third of the left main coronary artery (LMCA). Were calculated Grace Score and SYNTAX Score. Grace score - 117 high because of current chest pain and ECG changes. Figure 4

114 Figure 5: Left coronary artery Figure 6

115 Figure 7: Direct stenting with DES Figure 8: Final result Discussion In terms of mortality SYNTAX study showed no difference between PCI and CABG. The advantage of CABG was the reduction of repeat revascularization to 12% for CABG against 20% for PCI. Angiographic characteristics of left main stenosis are essential when choosing between PCI and CABG. Increasingly, the role of hybrid coronary revascularization a mammaria interna sinistra to LAD (LIMA - LAD) and PCI coronary artery different from the LAD. Of importance is the joint work of the Heart Team to explain to the patient what the angiographic finding is and what the treatment options are. The Doctor must explain the risks of his choice. Upon refusal

of surgical revascularization and appropriate anatomical characteristics of left main stenosis can proceed to coronary angioplasty. An important factor in the decision for the PCI should be the experience of the operator. Deciding to choose between the two revascularization is a complex process. We discussed characteristic of the stenosis, what is the experience of operator, suitable is patient for cardiac surgery and not least the choice of the patient. Bibliography 1. Перкутанни интервенции при стволови стенози - Доц. Д-р Ю. Джоргова (2008). 2. Bernard J Gersh., et al. The SYNTAX Trial. Circulation: Cardiovascular Interventions 109.8 (2009): 463-467. 3. Gilles Montalescot., et al. 2013 ESC Guidelines on the management of stable coronary artery disease. European Heart Journal 34 (2014): 2949-3003. 116 Volume 2 Issue 2 October 2015 All rights are reserved by Valentin Hristov.